SlideShare a Scribd company logo
COMPUTER APPLICATIONS IN
PHARMACEUTICAL RESEARCH AND
DEVELOPMENT.
Sujitha Mary
M Pharm
St Joseph College Of Pharmacy
1
CONTENTS
• DISCRIPTIVE VERSUS MECHANISTIC MODELLING
• STATISTICAL PARAMETERS
• ESTIMATION
• CONFIDENCE REGION
• NON LINEARITY AT THE OPTIMUM
• SENSITIVITY ANALYSIS
• OPTIMAL DESIGNS
• POPULATION MODELLING
2
DISCRIPTIVE VERSUS MECHANISTIC
MODELLING
3
4
5
6
7
8
.
9
10
11
STATISTICAL PARAMETERS
Dispersion (also called Variability, Scatter, Spread)
12
It is the extent to which a distribution is stretched
or squeezed.
Common examples of Statistical Dispersion are the
variance, standard deviation and interquartile
range.
Coefficient of Dispersion (COD)
It is a measure of spread that describes the amount of
variability relative to the mean and it is unit less.
𝑪𝑶𝑫= 𝝈∕𝝁∗𝟏𝟎𝟎
𝝈
𝝁
4
Variance:
13
It is the expectation of the squared deviation of a
random variable from its mean and it informally
measures how far a set of random numbers are
spread out from the mean.
It is calculated by taking the differences between each
number in the set and the mean, squaring the
differences (to make them positive) and diving the
sum of the squares by the number of values in the set.
The variance provides the user with a numerical
measure of the scatter of the data.𝝈 𝟐
=
𝑵
𝑵
= −𝝁 𝟐; 𝝁(𝑴
𝒆𝒂𝒏) =
𝑿𝑵
5
𝝈 𝟐= ∑(𝑿−𝝁) 𝟐∕∕ 𝑵= ∑𝑿 𝟐∕ 𝑵−𝝁 𝟐; 𝝁(𝑴𝒆𝒂𝒏)= ∑𝑿∕𝑵
Standard Déviation (SD) σ
14
It is a measure used to quantify the amount of
variation or dispersion of a set of data values.
It is a number that tells how measurement for a group
are spread out from the average (mean) or expected
value.
A low standard deviation means most of the numbers
are very close to the average while a high value
indicates the data to be spread out.
The SD provides the user with a numerical measure
of the scatter of the data.
𝝈=√𝟏∕𝑵 ∑(𝑿−𝝁)𝟐
Root Mean Squared Error
(RMSE)
15
It is also termed as Root Mean Square Deviation
(RMSD).
It is used to measure the differences between values
(sample and population values) predicted by a model
or an estimator and the values actually observed.
𝑹𝑴𝑺𝑬=√∑ (𝑿𝒐𝒃𝒅𝒆𝒓𝒗𝒆𝒅−𝑿𝒎𝒐𝒅𝒆𝒍𝒍𝒆𝒅)𝟐∕𝑵
Absolute Error (AE)
16
It is the magnitude of the difference between the
exact value and the approximation.
The relative error is the absolute error divided by the
magnitude of the exact value.
𝑨𝑬 = 𝑿 𝒎𝒆𝒂𝒔𝒖𝒓𝒆𝒅 −𝑿 𝒂𝒄𝒕𝒖𝒂𝒍
Mean Square Error (MSE)
17
Also termed as Mean Square Deviation (MSD).
It measures the average of the squares of the errors
or deviations i.e. the difference between the estimator
and that is estimated.
Factor Analysis
18
It is a useful tool for investigating variable
relationships for complex concepts allowing
researchers to investigate concepts that are not easily
measured directly by collapsing a large number of
variables into a few interpretable underlying factors.
STATISTICAL ESTIMATION
19
20
21
22
23
24
25
26
.
27
28
29
30
31
Confidence region
• In statistics, a confidence region is a multi-dimensional
generalization of a confidence interval. It is a set of points in
an n-dimensional space, often represented as an ellipsoid
around a point which is an estimated solution to a problem,
although other shapes can occur.
• Interpretation
• The confidence region is calculated in such a way that if a set
of measurements were repeated many times and a confidence
region calculated in the same way on each set of
measurements, then a certain percentage of the time (e.g. 95%)
the confidence region would include the point representing the
"true" values of the set of variables being estimated
32
.
• Nonlinear problems
• Confidence regions can be defined for any probability
distribution. The experimenter can choose the significance
level and the shape of the region, and then the size of the
region is determined by the probability distribution. A natural
choice is to use as a boundary a set of points with
constant (chi-squared) values.
• One approach is to use a linear approximation to the nonlinear
model, which may be a close approximation in the vicinity of
the solution, and then apply the analysis for a linear problem to
find an approximate confidence region. This may be a
reasonable approach if the confidence region is not very large
and the second derivatives of the model are also not very large.
33
.• Nonlinearity at the Optimum
• It is useful to study the degree of nonlinearity of our model in
a neighbourhood of the forecast.
• Briefly, there exist methods of assessing the maximum degree
of intrinsic nonlinearity that the model exhibits around the
optimum found. If maximum nonlinearity is excessive, for one
or more parameters the confidence regions obtained applying
the results of the classic theory are not to be trusted. In this
case, alternative simulation procedures may be employed to
provide empirical confidence regions.
34
SENSITIVITY ANALYSIS
• Sensitivity analysis is the study of how the uncertainty in the output of a
mathematical model or system (numerical or otherwise) can be divided and
allocated to different sources of uncertainty in its inputs[A related practice
is uncertainty analysis, which has a greater focus on uncertainty
quantification and propagation of uncertainty; ideally, uncertainty and
sensitivity analysis should be run in tandem.
• The process of recalculating outcomes under alternative assumptions to
determine the impact of a variable under sensitivity analysis can be useful
for a range of purposes including:
35
.
• Testing the robustness of the results of a model or system in the presence of
uncertainty.
• Increased understanding of the relationships between input and output
variables in a system or model.
• Uncertainty reduction, through the identification of model inputs that cause
significant uncertainty in the output and should therefore be the focus of
attention in order to increase robustness (perhaps by further research).
• Searching for errors in the model (by encountering unexpected
relationships between inputs and outputs).
• Model simplification – fixing model inputs that have no effect on the
output, or identifying and removing redundant parts of the model
structure.Enhancing communication from modellers to decision makers
(e.g. by making recommendations more credible, understandable,
compelling or persuasive). 36
.
• Settings and constraints
• The choice of method of sensitivity analysis is typically dictated by a
number of problem constraints or settings. Some of the most common are
• Computational expense: Sensitivity analysis is almost always performed by
running the model a (possibly large) number of times, i.e. a sampling-based
approach.
• The model has a large number of uncertain inputs. Sensitivity analysis is
essentially the exploration of the multidimensional input space, which
grows exponentially in size with the number of inputs. See the curse of
dimensionality.
• Correlated inputs: Most common sensitivity analysis methods assume
independence between model inputs, but sometimes inputs can be strongly
correlated. This is still an immature field of research and definitive
methods have yet to be established.
• Nonlinearity: Some sensitivity analysis approaches, such as those based on
linear regression, can inaccurately measure sensitivity when the model37
• Correlated inputs: Most common sensitivity analysis methods assume
independence between model inputs, but sometimes inputs can be strongly
correlated. This is still an immature field of research and definitive methods
have yet to be established.
• Nonlinearity: Some sensitivity analysis approaches, such as those based on
linear regression, can inaccurately measure sensitivity when the model
response is nonlinear with respect to its inputs. In such cases, variance-
based measures are more appropriate.
38
.• Sensitivity analysis methods
• There are a large number of approaches to performing a sensitivity
analysis, many of which have been developed to address one or more
of the constraints discussed above. They are also distinguished by the
type of sensitivity measure, be it based on (for example) variance
decompositions.
• Regression analysis, in the context of sensitivity analysis, involves
fitting a linear regression to the model response and using
standardized regression coefficients as direct measures of sensitivity.
• variance-based methods
• Variance-based are a class of probabilistic approaches which quantify
the input and output uncertainties as probability distributions, and
decompose the output variance into parts attributable to input
variables and combinations of variables. 39
Applications
• Chemistry
• Sensitivity analysis is common in many areas of physics and
chemistry.
• Sensitivity analysis has been proven to be a powerful tool to
investigate a complex kinetic model.
• In a meta analysis, a sensitivity analysis tests if the results are
sensitive to restrictions on the data included. Common
examples are large trials only, higher quality trials only, and
more recent trials only. If results are consistent it provides
stronger evidence of an effect and of generalizability.
Engineering
• Modern engineering design makes extensive use of computer
models to test designs before they are manufactured.
Sensitivity analysis allows designers to assess the effects and
sources of uncertainties, in the interest of building robust
models. 40
Optimal design
• In the design of experiments, optimal designs are a class of
experimental designs that are optimal with respect to some statistical
criterion.
• In the design of experiments for estimating statistical models, optimal
designs allow parameters to be estimated without bias and with
minimum variance.
• A non-optimal design requires a greater number of experimental runs
to estimate the parameters with the same precision as an optimal
design. In practical terms, optimal experiments can reduce the costs of
experimentation.
41
.
• Advantages
• Optimal designs reduce the costs of experimentation by
allowing statistical models to be estimated with fewer
experimental runs.
• Optimal designs can accommodate multiple types of
factors, such as process, mixture, and discrete factors.
• Designs can be optimized when the design-space is
constrained, for example, when the mathematical process-
space contains factor-settings that are practically infeasible
(e.g. due to safety concerns).
42
.
• Minimizing the variance of estimators
• Experimental designs are evaluated using statistical criteria.
• .In the estimation theory for statistical models with one real parameter, the
reciprocal of the variance of an ("efficient") estimator is called the "Fisher
information" for that estimator. Because of this reciprocity, minimizing the variance
corresponds to maximizing the information.
• When the statistical model has several parameters, however, the mean of the
parameter-estimator is a vector and its variance is a matrix.
• The inverse matrix of the variance-matrix is called the "information matrix".
Because the variance of the estimator of a parameter vector is a matrix, the problem
of "minimizing the variance" is complicated.
• Using statistical theory, statisticians compress the information-matrix using real-
valued summary statistics; being real-valued functions, these "information criteria"
can be maximized.
43
POPULATION MODELLING
• A population model is a type of mathematical model
that is applied to the study of population dynamics.
• Population modelling is a tool to identify and describe
relationships between a subject’s physiologic
characteristics and observed drug exposure or response.
Population pharmacokinetics (PK) modelling is not a
new concept; it was first introduced in 1972 by Sheiner
et al.
44
45
Figure represents a brief outline of some areas in which modelling and simulation are
commonly employed during drug development. Appropriate models can provide a
framework for predicting the time course of exposure and response for different dose
regimens. Central to this evolution has been the widespread adoption of population
modelling methods that provide a framework for quantitating and explaining variability
in drug exposure and response.
Types of Models
PK models
PK models describe the relationship between drug concentration(s) and time. The
building block of many PK models is a “compartment”—a region of the body in which
the drug is well mixed and kinetically homogenous (and can therefore be described in
terms of a single representative concentration at any time point).
46
Disease progression models
• Disease progression models were first used in 1992 to describe the time
course of a disease metric (e.g., ADASC in Alzheimer's disease).
• Such models also capture the inter-subject variability in disease
progression, and the manner in which the time course is influenced by
covariates or by treatment.
• They can be linked to a concurrent PK model and used to determine
whether a drug exhibits symptomatic activity or affects progression.
• Models of disease progress in placebo groups are crucial for
understanding the time course of the disease in treated groups, as well as
for predicting the likely response in a placebo group in a clinical trial
47
References
• 1.Computer application in pharmaceutical
research and development ,Sean Ekins 2006.
• Non linear regression analysis ,Bales and
Watts.
• www.slideshare.net.
• www.google.com 48

More Related Content

What's hot

COMPUTER SIMULATIONS IN PHARMACOKINETICS & PHARMACODYNAMICS
COMPUTER SIMULATIONS  IN  PHARMACOKINETICS & PHARMACODYNAMICSCOMPUTER SIMULATIONS  IN  PHARMACOKINETICS & PHARMACODYNAMICS
COMPUTER SIMULATIONS IN PHARMACOKINETICS & PHARMACODYNAMICS
sagartrivedi14
 
Descriptive versus mechanistic modelling
Descriptive versus mechanistic modellingDescriptive versus mechanistic modelling
Descriptive versus mechanistic modelling
Sayeda Salma S.A.
 
History of computers in pharmaceutical research and development
History of computers in pharmaceutical research and developmentHistory of computers in pharmaceutical research and development
History of computers in pharmaceutical research and development
Zahid1392
 
Computers in pharmaceutical research and development, General overview, Brief...
Computers in pharmaceutical research and development, General overview, Brief...Computers in pharmaceutical research and development, General overview, Brief...
Computers in pharmaceutical research and development, General overview, Brief...
Manikant Prasad Shah
 
Artificial Intelligence (AI), Robotics and Computational fluid dynamics (CFD)
Artificial Intelligence (AI), Robotics and Computational fluid dynamics (CFD) Artificial Intelligence (AI), Robotics and Computational fluid dynamics (CFD)
Artificial Intelligence (AI), Robotics and Computational fluid dynamics (CFD)
PRAJAKTASAWANT33
 
Computer simulation
Computer simulationComputer simulation
Computer simulation
shashi kiran
 
Computer aided formulation development
Computer aided formulation developmentComputer aided formulation development
Computer aided formulation development
Siddu K M
 
Computational modeling of drug disposition
Computational modeling of drug dispositionComputational modeling of drug disposition
Computational modeling of drug disposition
PV. Viji
 
Active transport
Active transportActive transport
Electrosomes preparation and application
Electrosomes preparation and applicationElectrosomes preparation and application
Electrosomes preparation and application
mahesh745
 
Computer aided formulation development
Computer aided formulation developmentComputer aided formulation development
Computer aided formulation development
Shruti Tyagi
 
Tumour targeting and Brain specific drug delivery
Tumour targeting and Brain specific drug deliveryTumour targeting and Brain specific drug delivery
Tumour targeting and Brain specific drug delivery
SHUBHAMGWAGH
 
LEGAL PROTECTION OF INNOVATIVE USES OF COMPUTERS IN R & D.pptx
LEGAL PROTECTION OF INNOVATIVE USES OF COMPUTERS IN R & D.pptxLEGAL PROTECTION OF INNOVATIVE USES OF COMPUTERS IN R & D.pptx
LEGAL PROTECTION OF INNOVATIVE USES OF COMPUTERS IN R & D.pptx
Tanvi Mhashakhetri
 
Ethics of computing in pharmaceutical research
Ethics of computing in pharmaceutical researchEthics of computing in pharmaceutical research
Ethics of computing in pharmaceutical research
SUJITHA MARY
 
Computational modeling in drug disposition
Computational modeling in drug dispositionComputational modeling in drug disposition
Computational modeling in drug disposition
SUJITHA MARY
 
GIT Absorption Simulation
GIT Absorption SimulationGIT Absorption Simulation
GIT Absorption Simulation
JaskiranKaur72
 
Biological process involved in drug targetting
Biological process involved  in drug targettingBiological process involved  in drug targetting
Biological process involved in drug targetting
Sayeda Salma S.A.
 
computers in clinical development
 computers in clinical development computers in clinical development
computers in clinical development
SUJITHA MARY
 
Computers in Pharmaceutical formulation
Computers in Pharmaceutical formulationComputers in Pharmaceutical formulation
Computers in Pharmaceutical formulation
sonalsuryawanshi2
 
Computers in Pharmaceutical emulsion development.
Computers in Pharmaceutical emulsion development. Computers in Pharmaceutical emulsion development.
Computers in Pharmaceutical emulsion development.
Arpitha Aarushi
 

What's hot (20)

COMPUTER SIMULATIONS IN PHARMACOKINETICS & PHARMACODYNAMICS
COMPUTER SIMULATIONS  IN  PHARMACOKINETICS & PHARMACODYNAMICSCOMPUTER SIMULATIONS  IN  PHARMACOKINETICS & PHARMACODYNAMICS
COMPUTER SIMULATIONS IN PHARMACOKINETICS & PHARMACODYNAMICS
 
Descriptive versus mechanistic modelling
Descriptive versus mechanistic modellingDescriptive versus mechanistic modelling
Descriptive versus mechanistic modelling
 
History of computers in pharmaceutical research and development
History of computers in pharmaceutical research and developmentHistory of computers in pharmaceutical research and development
History of computers in pharmaceutical research and development
 
Computers in pharmaceutical research and development, General overview, Brief...
Computers in pharmaceutical research and development, General overview, Brief...Computers in pharmaceutical research and development, General overview, Brief...
Computers in pharmaceutical research and development, General overview, Brief...
 
Artificial Intelligence (AI), Robotics and Computational fluid dynamics (CFD)
Artificial Intelligence (AI), Robotics and Computational fluid dynamics (CFD) Artificial Intelligence (AI), Robotics and Computational fluid dynamics (CFD)
Artificial Intelligence (AI), Robotics and Computational fluid dynamics (CFD)
 
Computer simulation
Computer simulationComputer simulation
Computer simulation
 
Computer aided formulation development
Computer aided formulation developmentComputer aided formulation development
Computer aided formulation development
 
Computational modeling of drug disposition
Computational modeling of drug dispositionComputational modeling of drug disposition
Computational modeling of drug disposition
 
Active transport
Active transportActive transport
Active transport
 
Electrosomes preparation and application
Electrosomes preparation and applicationElectrosomes preparation and application
Electrosomes preparation and application
 
Computer aided formulation development
Computer aided formulation developmentComputer aided formulation development
Computer aided formulation development
 
Tumour targeting and Brain specific drug delivery
Tumour targeting and Brain specific drug deliveryTumour targeting and Brain specific drug delivery
Tumour targeting and Brain specific drug delivery
 
LEGAL PROTECTION OF INNOVATIVE USES OF COMPUTERS IN R & D.pptx
LEGAL PROTECTION OF INNOVATIVE USES OF COMPUTERS IN R & D.pptxLEGAL PROTECTION OF INNOVATIVE USES OF COMPUTERS IN R & D.pptx
LEGAL PROTECTION OF INNOVATIVE USES OF COMPUTERS IN R & D.pptx
 
Ethics of computing in pharmaceutical research
Ethics of computing in pharmaceutical researchEthics of computing in pharmaceutical research
Ethics of computing in pharmaceutical research
 
Computational modeling in drug disposition
Computational modeling in drug dispositionComputational modeling in drug disposition
Computational modeling in drug disposition
 
GIT Absorption Simulation
GIT Absorption SimulationGIT Absorption Simulation
GIT Absorption Simulation
 
Biological process involved in drug targetting
Biological process involved  in drug targettingBiological process involved  in drug targetting
Biological process involved in drug targetting
 
computers in clinical development
 computers in clinical development computers in clinical development
computers in clinical development
 
Computers in Pharmaceutical formulation
Computers in Pharmaceutical formulationComputers in Pharmaceutical formulation
Computers in Pharmaceutical formulation
 
Computers in Pharmaceutical emulsion development.
Computers in Pharmaceutical emulsion development. Computers in Pharmaceutical emulsion development.
Computers in Pharmaceutical emulsion development.
 

Similar to computer application in pharmaceutical research

Basic geostatistics
Basic geostatisticsBasic geostatistics
Basic geostatistics
Serdar Kaya
 
cadd.pptx
cadd.pptxcadd.pptx
Res701 research methodology lecture 7 8-devaprakasam
Res701 research methodology lecture 7 8-devaprakasamRes701 research methodology lecture 7 8-devaprakasam
Res701 research methodology lecture 7 8-devaprakasam
VIT University (Chennai Campus)
 
Presentation1
Presentation1Presentation1
Presentation1
Nalini Singh
 
man0 ppt.pptx
man0 ppt.pptxman0 ppt.pptx
man0 ppt.pptx
ManojKumarr75
 
Sensitivity Analysis, Optimal Design, Population Modeling.pptx
Sensitivity Analysis, Optimal Design, Population Modeling.pptxSensitivity Analysis, Optimal Design, Population Modeling.pptx
Sensitivity Analysis, Optimal Design, Population Modeling.pptx
AditiChauhan701637
 
Introduction to sampling
Introduction to samplingIntroduction to sampling
Introduction to samplingSituo Liu
 
Outlier analysis and anomaly detection
Outlier analysis and anomaly detectionOutlier analysis and anomaly detection
Outlier analysis and anomaly detection
ShantanuDeosthale
 
Anomaly detection Meetup Slides
Anomaly detection Meetup SlidesAnomaly detection Meetup Slides
Anomaly detection Meetup Slides
QuantUniversity
 
Regression analysis made easy
Regression analysis made easyRegression analysis made easy
Regression analysis made easy
Weam Banjar
 
Overview of the Possibilities of Quantitative Methods in Political Science
Overview of the Possibilities of Quantitative Methods in Political ScienceOverview of the Possibilities of Quantitative Methods in Political Science
Overview of the Possibilities of Quantitative Methods in Political Science
environmentalconflicts
 
Biostatistics and Research Methodology Semester 8
Biostatistics and Research Methodology Semester 8Biostatistics and Research Methodology Semester 8
Biostatistics and Research Methodology Semester 8
ParulSharma130721
 
PEMF2_SDM_2012_Ali
PEMF2_SDM_2012_AliPEMF2_SDM_2012_Ali
PEMF2_SDM_2012_Ali
MDO_Lab
 
Descriptive Analytics: Data Reduction
 Descriptive Analytics: Data Reduction Descriptive Analytics: Data Reduction
Descriptive Analytics: Data Reduction
Nguyen Ngoc Binh Phuong
 
Sensitivity analysis
Sensitivity analysisSensitivity analysis
Sensitivity analysis
sunilgv06
 
Anomaly detection: Core Techniques and Advances in Big Data and Deep Learning
Anomaly detection: Core Techniques and Advances in Big Data and Deep LearningAnomaly detection: Core Techniques and Advances in Big Data and Deep Learning
Anomaly detection: Core Techniques and Advances in Big Data and Deep Learning
QuantUniversity
 
Sampling distribution
Sampling distributionSampling distribution
Sampling distribution
swarna dey
 
descriptive data analysis
 descriptive data analysis descriptive data analysis
descriptive data analysis
gnanasarita1
 
Standard deviation
Standard deviationStandard deviation
Standard deviation
M K
 

Similar to computer application in pharmaceutical research (20)

Basic geostatistics
Basic geostatisticsBasic geostatistics
Basic geostatistics
 
cadd.pptx
cadd.pptxcadd.pptx
cadd.pptx
 
Res701 research methodology lecture 7 8-devaprakasam
Res701 research methodology lecture 7 8-devaprakasamRes701 research methodology lecture 7 8-devaprakasam
Res701 research methodology lecture 7 8-devaprakasam
 
Presentation1
Presentation1Presentation1
Presentation1
 
man0 ppt.pptx
man0 ppt.pptxman0 ppt.pptx
man0 ppt.pptx
 
Sensitivity Analysis, Optimal Design, Population Modeling.pptx
Sensitivity Analysis, Optimal Design, Population Modeling.pptxSensitivity Analysis, Optimal Design, Population Modeling.pptx
Sensitivity Analysis, Optimal Design, Population Modeling.pptx
 
Introduction to sampling
Introduction to samplingIntroduction to sampling
Introduction to sampling
 
Outlier analysis and anomaly detection
Outlier analysis and anomaly detectionOutlier analysis and anomaly detection
Outlier analysis and anomaly detection
 
Anomaly detection Meetup Slides
Anomaly detection Meetup SlidesAnomaly detection Meetup Slides
Anomaly detection Meetup Slides
 
Regression analysis made easy
Regression analysis made easyRegression analysis made easy
Regression analysis made easy
 
Overview of the Possibilities of Quantitative Methods in Political Science
Overview of the Possibilities of Quantitative Methods in Political ScienceOverview of the Possibilities of Quantitative Methods in Political Science
Overview of the Possibilities of Quantitative Methods in Political Science
 
Biostatistics and Research Methodology Semester 8
Biostatistics and Research Methodology Semester 8Biostatistics and Research Methodology Semester 8
Biostatistics and Research Methodology Semester 8
 
PEMF2_SDM_2012_Ali
PEMF2_SDM_2012_AliPEMF2_SDM_2012_Ali
PEMF2_SDM_2012_Ali
 
Descriptive Analytics: Data Reduction
 Descriptive Analytics: Data Reduction Descriptive Analytics: Data Reduction
Descriptive Analytics: Data Reduction
 
Sensitivity analysis
Sensitivity analysisSensitivity analysis
Sensitivity analysis
 
Anomaly detection: Core Techniques and Advances in Big Data and Deep Learning
Anomaly detection: Core Techniques and Advances in Big Data and Deep LearningAnomaly detection: Core Techniques and Advances in Big Data and Deep Learning
Anomaly detection: Core Techniques and Advances in Big Data and Deep Learning
 
Statistics
StatisticsStatistics
Statistics
 
Sampling distribution
Sampling distributionSampling distribution
Sampling distribution
 
descriptive data analysis
 descriptive data analysis descriptive data analysis
descriptive data analysis
 
Standard deviation
Standard deviationStandard deviation
Standard deviation
 

More from SUJITHA MARY

POWDERS.pptx
POWDERS.pptxPOWDERS.pptx
POWDERS.pptx
SUJITHA MARY
 
LIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptxLIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptx
SUJITHA MARY
 
DOSAGE FORM.pptx
DOSAGE FORM.pptxDOSAGE FORM.pptx
DOSAGE FORM.pptx
SUJITHA MARY
 
COMPLAINTS. UNIT IV
COMPLAINTS. UNIT IVCOMPLAINTS. UNIT IV
COMPLAINTS. UNIT IV
SUJITHA MARY
 
Quality by deign
Quality by deignQuality by deign
Quality by deign
SUJITHA MARY
 
Good laboratoty practise
Good laboratoty practise Good laboratoty practise
Good laboratoty practise
SUJITHA MARY
 
calibration-and-validation
calibration-and-validationcalibration-and-validation
calibration-and-validation
SUJITHA MARY
 
warehousing
warehousingwarehousing
warehousing
SUJITHA MARY
 
Nanoparticle for drug delivery system
Nanoparticle for drug delivery systemNanoparticle for drug delivery system
Nanoparticle for drug delivery system
SUJITHA MARY
 
Drug absorption from the gastrointestinal tract
Drug absorption from the gastrointestinal tractDrug absorption from the gastrointestinal tract
Drug absorption from the gastrointestinal tract
SUJITHA MARY
 
Pharmacokinetics&pharmacodynamics of biotechnological pdts
Pharmacokinetics&pharmacodynamics of biotechnological pdtsPharmacokinetics&pharmacodynamics of biotechnological pdts
Pharmacokinetics&pharmacodynamics of biotechnological pdts
SUJITHA MARY
 
Modified release drug products
Modified release drug productsModified release drug products
Modified release drug products
SUJITHA MARY
 
Biopharmaceutic considerations in drug product design and in
Biopharmaceutic considerations in drug product design and inBiopharmaceutic considerations in drug product design and in
Biopharmaceutic considerations in drug product design and in
SUJITHA MARY
 
Computers in pharmaceutical research and development
Computers in pharmaceutical research and developmentComputers in pharmaceutical research and development
Computers in pharmaceutical research and development
SUJITHA MARY
 
Computational modelling of drug disposition active transport
Computational modelling of  drug disposition active transportComputational modelling of  drug disposition active transport
Computational modelling of drug disposition active transport
SUJITHA MARY
 
Surfactants classification and application in cosmetics
Surfactants   classification and application in cosmetics Surfactants   classification and application in cosmetics
Surfactants classification and application in cosmetics
SUJITHA MARY
 
Transport models biopharamaceutics
Transport models biopharamaceuticsTransport models biopharamaceutics
Transport models biopharamaceutics
SUJITHA MARY
 
targeted drug delivery slide
 targeted  drug delivery slide targeted  drug delivery slide
targeted drug delivery slide
SUJITHA MARY
 
Emulsions and microemulsions- computer in pharmaceutical formulatation
Emulsions and microemulsions- computer in pharmaceutical formulatationEmulsions and microemulsions- computer in pharmaceutical formulatation
Emulsions and microemulsions- computer in pharmaceutical formulatation
SUJITHA MARY
 
Viral and non viral gene transfer
Viral and non viral gene transferViral and non viral gene transfer
Viral and non viral gene transfer
SUJITHA MARY
 

More from SUJITHA MARY (20)

POWDERS.pptx
POWDERS.pptxPOWDERS.pptx
POWDERS.pptx
 
LIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptxLIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptx
 
DOSAGE FORM.pptx
DOSAGE FORM.pptxDOSAGE FORM.pptx
DOSAGE FORM.pptx
 
COMPLAINTS. UNIT IV
COMPLAINTS. UNIT IVCOMPLAINTS. UNIT IV
COMPLAINTS. UNIT IV
 
Quality by deign
Quality by deignQuality by deign
Quality by deign
 
Good laboratoty practise
Good laboratoty practise Good laboratoty practise
Good laboratoty practise
 
calibration-and-validation
calibration-and-validationcalibration-and-validation
calibration-and-validation
 
warehousing
warehousingwarehousing
warehousing
 
Nanoparticle for drug delivery system
Nanoparticle for drug delivery systemNanoparticle for drug delivery system
Nanoparticle for drug delivery system
 
Drug absorption from the gastrointestinal tract
Drug absorption from the gastrointestinal tractDrug absorption from the gastrointestinal tract
Drug absorption from the gastrointestinal tract
 
Pharmacokinetics&pharmacodynamics of biotechnological pdts
Pharmacokinetics&pharmacodynamics of biotechnological pdtsPharmacokinetics&pharmacodynamics of biotechnological pdts
Pharmacokinetics&pharmacodynamics of biotechnological pdts
 
Modified release drug products
Modified release drug productsModified release drug products
Modified release drug products
 
Biopharmaceutic considerations in drug product design and in
Biopharmaceutic considerations in drug product design and inBiopharmaceutic considerations in drug product design and in
Biopharmaceutic considerations in drug product design and in
 
Computers in pharmaceutical research and development
Computers in pharmaceutical research and developmentComputers in pharmaceutical research and development
Computers in pharmaceutical research and development
 
Computational modelling of drug disposition active transport
Computational modelling of  drug disposition active transportComputational modelling of  drug disposition active transport
Computational modelling of drug disposition active transport
 
Surfactants classification and application in cosmetics
Surfactants   classification and application in cosmetics Surfactants   classification and application in cosmetics
Surfactants classification and application in cosmetics
 
Transport models biopharamaceutics
Transport models biopharamaceuticsTransport models biopharamaceutics
Transport models biopharamaceutics
 
targeted drug delivery slide
 targeted  drug delivery slide targeted  drug delivery slide
targeted drug delivery slide
 
Emulsions and microemulsions- computer in pharmaceutical formulatation
Emulsions and microemulsions- computer in pharmaceutical formulatationEmulsions and microemulsions- computer in pharmaceutical formulatation
Emulsions and microemulsions- computer in pharmaceutical formulatation
 
Viral and non viral gene transfer
Viral and non viral gene transferViral and non viral gene transfer
Viral and non viral gene transfer
 

Recently uploaded

GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
Areesha Ahmad
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
muralinath2
 
filosofia boliviana introducción jsjdjd.pptx
filosofia boliviana introducción jsjdjd.pptxfilosofia boliviana introducción jsjdjd.pptx
filosofia boliviana introducción jsjdjd.pptx
IvanMallco1
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
muralinath2
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
Scintica Instrumentation
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
pablovgd
 
EY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxEY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptx
AlguinaldoKong
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
SAMIR PANDA
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
Richard Gill
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
NathanBaughman3
 
Penicillin...........................pptx
Penicillin...........................pptxPenicillin...........................pptx
Penicillin...........................pptx
Cherry
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
Sérgio Sacani
 
Mammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also FunctionsMammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also Functions
YOGESH DOGRA
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
muralinath2
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
sachin783648
 
Large scale production of streptomycin.pptx
Large scale production of streptomycin.pptxLarge scale production of streptomycin.pptx
Large scale production of streptomycin.pptx
Cherry
 
Viksit bharat till 2047 India@2047.pptx
Viksit bharat till 2047  India@2047.pptxViksit bharat till 2047  India@2047.pptx
Viksit bharat till 2047 India@2047.pptx
rakeshsharma20142015
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
silvermistyshot
 

Recently uploaded (20)

GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
 
filosofia boliviana introducción jsjdjd.pptx
filosofia boliviana introducción jsjdjd.pptxfilosofia boliviana introducción jsjdjd.pptx
filosofia boliviana introducción jsjdjd.pptx
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
 
EY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxEY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptx
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
 
Penicillin...........................pptx
Penicillin...........................pptxPenicillin...........................pptx
Penicillin...........................pptx
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
 
Mammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also FunctionsMammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also Functions
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
 
Large scale production of streptomycin.pptx
Large scale production of streptomycin.pptxLarge scale production of streptomycin.pptx
Large scale production of streptomycin.pptx
 
Viksit bharat till 2047 India@2047.pptx
Viksit bharat till 2047  India@2047.pptxViksit bharat till 2047  India@2047.pptx
Viksit bharat till 2047 India@2047.pptx
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
 

computer application in pharmaceutical research

  • 1. COMPUTER APPLICATIONS IN PHARMACEUTICAL RESEARCH AND DEVELOPMENT. Sujitha Mary M Pharm St Joseph College Of Pharmacy 1
  • 2. CONTENTS • DISCRIPTIVE VERSUS MECHANISTIC MODELLING • STATISTICAL PARAMETERS • ESTIMATION • CONFIDENCE REGION • NON LINEARITY AT THE OPTIMUM • SENSITIVITY ANALYSIS • OPTIMAL DESIGNS • POPULATION MODELLING 2
  • 4. 4
  • 5. 5
  • 6. 6
  • 7. 7
  • 8. 8
  • 9. . 9
  • 10. 10
  • 11. 11
  • 12. STATISTICAL PARAMETERS Dispersion (also called Variability, Scatter, Spread) 12 It is the extent to which a distribution is stretched or squeezed. Common examples of Statistical Dispersion are the variance, standard deviation and interquartile range. Coefficient of Dispersion (COD) It is a measure of spread that describes the amount of variability relative to the mean and it is unit less. 𝑪𝑶𝑫= 𝝈∕𝝁∗𝟏𝟎𝟎 𝝈 𝝁 4
  • 13. Variance: 13 It is the expectation of the squared deviation of a random variable from its mean and it informally measures how far a set of random numbers are spread out from the mean. It is calculated by taking the differences between each number in the set and the mean, squaring the differences (to make them positive) and diving the sum of the squares by the number of values in the set. The variance provides the user with a numerical measure of the scatter of the data.𝝈 𝟐 = 𝑵 𝑵 = −𝝁 𝟐; 𝝁(𝑴 𝒆𝒂𝒏) = 𝑿𝑵 5 𝝈 𝟐= ∑(𝑿−𝝁) 𝟐∕∕ 𝑵= ∑𝑿 𝟐∕ 𝑵−𝝁 𝟐; 𝝁(𝑴𝒆𝒂𝒏)= ∑𝑿∕𝑵
  • 14. Standard Déviation (SD) σ 14 It is a measure used to quantify the amount of variation or dispersion of a set of data values. It is a number that tells how measurement for a group are spread out from the average (mean) or expected value. A low standard deviation means most of the numbers are very close to the average while a high value indicates the data to be spread out. The SD provides the user with a numerical measure of the scatter of the data. 𝝈=√𝟏∕𝑵 ∑(𝑿−𝝁)𝟐
  • 15. Root Mean Squared Error (RMSE) 15 It is also termed as Root Mean Square Deviation (RMSD). It is used to measure the differences between values (sample and population values) predicted by a model or an estimator and the values actually observed. 𝑹𝑴𝑺𝑬=√∑ (𝑿𝒐𝒃𝒅𝒆𝒓𝒗𝒆𝒅−𝑿𝒎𝒐𝒅𝒆𝒍𝒍𝒆𝒅)𝟐∕𝑵
  • 16. Absolute Error (AE) 16 It is the magnitude of the difference between the exact value and the approximation. The relative error is the absolute error divided by the magnitude of the exact value. 𝑨𝑬 = 𝑿 𝒎𝒆𝒂𝒔𝒖𝒓𝒆𝒅 −𝑿 𝒂𝒄𝒕𝒖𝒂𝒍
  • 17. Mean Square Error (MSE) 17 Also termed as Mean Square Deviation (MSD). It measures the average of the squares of the errors or deviations i.e. the difference between the estimator and that is estimated.
  • 18. Factor Analysis 18 It is a useful tool for investigating variable relationships for complex concepts allowing researchers to investigate concepts that are not easily measured directly by collapsing a large number of variables into a few interpretable underlying factors.
  • 20. 20
  • 21. 21
  • 22. 22
  • 23. 23
  • 24. 24
  • 25. 25
  • 26. 26
  • 27. . 27
  • 28. 28
  • 29. 29
  • 30. 30
  • 31. 31
  • 32. Confidence region • In statistics, a confidence region is a multi-dimensional generalization of a confidence interval. It is a set of points in an n-dimensional space, often represented as an ellipsoid around a point which is an estimated solution to a problem, although other shapes can occur. • Interpretation • The confidence region is calculated in such a way that if a set of measurements were repeated many times and a confidence region calculated in the same way on each set of measurements, then a certain percentage of the time (e.g. 95%) the confidence region would include the point representing the "true" values of the set of variables being estimated 32
  • 33. . • Nonlinear problems • Confidence regions can be defined for any probability distribution. The experimenter can choose the significance level and the shape of the region, and then the size of the region is determined by the probability distribution. A natural choice is to use as a boundary a set of points with constant (chi-squared) values. • One approach is to use a linear approximation to the nonlinear model, which may be a close approximation in the vicinity of the solution, and then apply the analysis for a linear problem to find an approximate confidence region. This may be a reasonable approach if the confidence region is not very large and the second derivatives of the model are also not very large. 33
  • 34. .• Nonlinearity at the Optimum • It is useful to study the degree of nonlinearity of our model in a neighbourhood of the forecast. • Briefly, there exist methods of assessing the maximum degree of intrinsic nonlinearity that the model exhibits around the optimum found. If maximum nonlinearity is excessive, for one or more parameters the confidence regions obtained applying the results of the classic theory are not to be trusted. In this case, alternative simulation procedures may be employed to provide empirical confidence regions. 34
  • 35. SENSITIVITY ANALYSIS • Sensitivity analysis is the study of how the uncertainty in the output of a mathematical model or system (numerical or otherwise) can be divided and allocated to different sources of uncertainty in its inputs[A related practice is uncertainty analysis, which has a greater focus on uncertainty quantification and propagation of uncertainty; ideally, uncertainty and sensitivity analysis should be run in tandem. • The process of recalculating outcomes under alternative assumptions to determine the impact of a variable under sensitivity analysis can be useful for a range of purposes including: 35
  • 36. . • Testing the robustness of the results of a model or system in the presence of uncertainty. • Increased understanding of the relationships between input and output variables in a system or model. • Uncertainty reduction, through the identification of model inputs that cause significant uncertainty in the output and should therefore be the focus of attention in order to increase robustness (perhaps by further research). • Searching for errors in the model (by encountering unexpected relationships between inputs and outputs). • Model simplification – fixing model inputs that have no effect on the output, or identifying and removing redundant parts of the model structure.Enhancing communication from modellers to decision makers (e.g. by making recommendations more credible, understandable, compelling or persuasive). 36
  • 37. . • Settings and constraints • The choice of method of sensitivity analysis is typically dictated by a number of problem constraints or settings. Some of the most common are • Computational expense: Sensitivity analysis is almost always performed by running the model a (possibly large) number of times, i.e. a sampling-based approach. • The model has a large number of uncertain inputs. Sensitivity analysis is essentially the exploration of the multidimensional input space, which grows exponentially in size with the number of inputs. See the curse of dimensionality. • Correlated inputs: Most common sensitivity analysis methods assume independence between model inputs, but sometimes inputs can be strongly correlated. This is still an immature field of research and definitive methods have yet to be established. • Nonlinearity: Some sensitivity analysis approaches, such as those based on linear regression, can inaccurately measure sensitivity when the model37
  • 38. • Correlated inputs: Most common sensitivity analysis methods assume independence between model inputs, but sometimes inputs can be strongly correlated. This is still an immature field of research and definitive methods have yet to be established. • Nonlinearity: Some sensitivity analysis approaches, such as those based on linear regression, can inaccurately measure sensitivity when the model response is nonlinear with respect to its inputs. In such cases, variance- based measures are more appropriate. 38
  • 39. .• Sensitivity analysis methods • There are a large number of approaches to performing a sensitivity analysis, many of which have been developed to address one or more of the constraints discussed above. They are also distinguished by the type of sensitivity measure, be it based on (for example) variance decompositions. • Regression analysis, in the context of sensitivity analysis, involves fitting a linear regression to the model response and using standardized regression coefficients as direct measures of sensitivity. • variance-based methods • Variance-based are a class of probabilistic approaches which quantify the input and output uncertainties as probability distributions, and decompose the output variance into parts attributable to input variables and combinations of variables. 39
  • 40. Applications • Chemistry • Sensitivity analysis is common in many areas of physics and chemistry. • Sensitivity analysis has been proven to be a powerful tool to investigate a complex kinetic model. • In a meta analysis, a sensitivity analysis tests if the results are sensitive to restrictions on the data included. Common examples are large trials only, higher quality trials only, and more recent trials only. If results are consistent it provides stronger evidence of an effect and of generalizability. Engineering • Modern engineering design makes extensive use of computer models to test designs before they are manufactured. Sensitivity analysis allows designers to assess the effects and sources of uncertainties, in the interest of building robust models. 40
  • 41. Optimal design • In the design of experiments, optimal designs are a class of experimental designs that are optimal with respect to some statistical criterion. • In the design of experiments for estimating statistical models, optimal designs allow parameters to be estimated without bias and with minimum variance. • A non-optimal design requires a greater number of experimental runs to estimate the parameters with the same precision as an optimal design. In practical terms, optimal experiments can reduce the costs of experimentation. 41
  • 42. . • Advantages • Optimal designs reduce the costs of experimentation by allowing statistical models to be estimated with fewer experimental runs. • Optimal designs can accommodate multiple types of factors, such as process, mixture, and discrete factors. • Designs can be optimized when the design-space is constrained, for example, when the mathematical process- space contains factor-settings that are practically infeasible (e.g. due to safety concerns). 42
  • 43. . • Minimizing the variance of estimators • Experimental designs are evaluated using statistical criteria. • .In the estimation theory for statistical models with one real parameter, the reciprocal of the variance of an ("efficient") estimator is called the "Fisher information" for that estimator. Because of this reciprocity, minimizing the variance corresponds to maximizing the information. • When the statistical model has several parameters, however, the mean of the parameter-estimator is a vector and its variance is a matrix. • The inverse matrix of the variance-matrix is called the "information matrix". Because the variance of the estimator of a parameter vector is a matrix, the problem of "minimizing the variance" is complicated. • Using statistical theory, statisticians compress the information-matrix using real- valued summary statistics; being real-valued functions, these "information criteria" can be maximized. 43
  • 44. POPULATION MODELLING • A population model is a type of mathematical model that is applied to the study of population dynamics. • Population modelling is a tool to identify and describe relationships between a subject’s physiologic characteristics and observed drug exposure or response. Population pharmacokinetics (PK) modelling is not a new concept; it was first introduced in 1972 by Sheiner et al. 44
  • 45. 45
  • 46. Figure represents a brief outline of some areas in which modelling and simulation are commonly employed during drug development. Appropriate models can provide a framework for predicting the time course of exposure and response for different dose regimens. Central to this evolution has been the widespread adoption of population modelling methods that provide a framework for quantitating and explaining variability in drug exposure and response. Types of Models PK models PK models describe the relationship between drug concentration(s) and time. The building block of many PK models is a “compartment”—a region of the body in which the drug is well mixed and kinetically homogenous (and can therefore be described in terms of a single representative concentration at any time point). 46
  • 47. Disease progression models • Disease progression models were first used in 1992 to describe the time course of a disease metric (e.g., ADASC in Alzheimer's disease). • Such models also capture the inter-subject variability in disease progression, and the manner in which the time course is influenced by covariates or by treatment. • They can be linked to a concurrent PK model and used to determine whether a drug exhibits symptomatic activity or affects progression. • Models of disease progress in placebo groups are crucial for understanding the time course of the disease in treated groups, as well as for predicting the likely response in a placebo group in a clinical trial 47
  • 48. References • 1.Computer application in pharmaceutical research and development ,Sean Ekins 2006. • Non linear regression analysis ,Bales and Watts. • www.slideshare.net. • www.google.com 48